Fennec Pharmaceuticals (NASDAQ: FENC) reported Q4 EPS of ($0.10), $0.10 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $9.73 million versus the consensus estimate of $8.36 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.